XH001

XH001 · Peking Union Medical College Hospital

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for XH001, covering 2025-08-11 to 2026-02-25. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial on the Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-specific T-cell Injection in Advanced Gastric Cancer [Phase 1]

See pricing